{
  "resourceType": "Observation",
  "id": "TransurethralEnucleationDiagnosticConclusionGrouper",
  "meta": {
    "profile": [
      "https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/StructureDefinition/mii-pr-patho-diagnostic-conclusion-grouper|2026.0.0"
    ]
  },
  "category": [
    {
      "coding": [
        {
          "system": "http://terminology.hl7.org/CodeSystem/observation-category",
          "code": "laboratory"
        }
      ]
    }
  ],
  "performer": [
    {
      "reference": "Practitioner/PathologistPractitioner"
    }
  ],
  "basedOn": [
    {
      "reference": "ServiceRequest/TransurethralEnucleationReportRequest"
    }
  ],
  "derivedFrom": [
    {
      "reference": "QuestionnaireResponse/QuestionnaireResponseTransurethralEnucleation"
    }
  ],
  "hasMember": [
    {
      "reference": "Observation/TransurethralEnucleationHistologicalTypeICDO3"
    },
    {
      "reference": "Observation/TransurethralEnucleationMorphologyFreeText"
    },
    {
      "reference": "Observation/TransurethralEnucleationPrimaryGleasonPattern"
    },
    {
      "reference": "Observation/TransurethralEnucleationSecondaryGleasonPattern"
    },
    {
      "reference": "Observation/TransurethralEnucleationGleasonScoreTotal"
    },
    {
      "reference": "Observation/TransurethralEnucleationPercentageGleason45"
    },
    {
      "reference": "Observation/TransurethralEnucleationGradingGroupISUP"
    },
    {
      "reference": "Observation/TransurethralEnucleationIntraductalCarcinoma"
    },
    {
      "reference": "Observation/TransurethralEnucleationInvasiveCribriformCarcinoma"
    },
    {
      "reference": "Observation/TransurethralEnucleationProstaticTissueInvolved"
    },
    {
      "reference": "Observation/TransurethralEnucleationExtraprostaticExtension"
    },
    {
      "reference": "Observation/TransurethralEnucleationSeminalVesicleInvasion"
    },
    {
      "reference": "Observation/TransurethralEnucleationLymphovascularInvasion"
    },
    {
      "reference": "Observation/TransurethralEnucleationPerineuralInfiltration"
    }
  ],
  "note": [
    {
      "authorReference": {
        "reference": "Practitioner/PathologistPractitioner"
      },
      "time": "2024-05-12",
      "text": "Diagnose: Azinäres Adenokarzinom der Prostata (ICD-O 8140/3) mit invasiven kribriformen Anteilen und intraduktaler Karzinomkomponente. Gleason-Score 4+5=9, ISUP-Gradgruppe 5 (WHO 2016). Prozentualer Anteil Gleasonmuster 4 und 5: 90%. Ausgedehnte Tumorinfiltration, ca. 60% des Prostatagewebes befallen. Extraprostatische Ausbreitung nachgewiesen. Samenblaseninfiltration nachgewiesen. Lymphovaskuläre Invasion nachgewiesen. Perineurale Infiltration nachgewiesen. Empfehlung: Staging-Untersuchungen und interdisziplinäre Tumorkonferenz."
    }
  ],
  "code": {
    "coding": [
      {
        "system": "http://loinc.org",
        "code": "22637-3"
      }
    ]
  },
  "status": "final",
  "subject": {
    "reference": "Patient/Patient3"
  },
  "effectiveDateTime": "2024-05-12"
}
